MIRA INFORM REPORT

 

 

Report No. :

341399

Report Date :

16.09.2015

 

IDENTIFICATION DETAILS

 

Name :

ALVITA PHARMA PRIVATE LIMITED

 

 

Registered Office :

B 203, Gopal Palace, Near Nehru Nagar Circle, Satellite Road, Ambavadi, Ahmedabad – 380015, Gujarat

Tel. No.:

91-79-2671152

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

23.01.2010

 

 

Com. Reg. No.:

04-059305

 

 

Capital Investment / Paid-up Capital :

Rs.1.000 Million

 

 

CIN No.:

[Company Identification No.]

U24230GJ2010PTC059305

 

 

IEC No.:

0809026384

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMA09495D

 

 

PAN No.:

[Permanent Account No.]

AAICA1744Q

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing, Trading and Exporting of Pharmaceuticals Products.

 

 

No. of Employees :

40 (Approximately) 

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (54)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 100000

 

 

Status :

Good 

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2010 and it is a manufacturer and trader of pharmaceutical products.

 

For the financial year ended 2014, company has reported growth of 93.12% on total revenue of Rs. 253.783 Million against the total revenue of Rs. 131.952 Million and company has maintained decent net profit margin at 8.10%.

 

Rating takes into consideration company’s sound financial risk profile marked by satisfactory networth base and with zero debt balance sheet profile of the company.

 

Trade relations are reported as fair. Payments are reported to be regular and as per commitment.

 

In view of aforesaid, the company can be considered good for normal business dealings at usual trade terms and conditions.

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

 

INFORMATION PARTED BY

 

Name :

Ms. Pooja

Designation :

Accounts Departmen

Contact No.:

91-22-28991496 / 27540468

Date :

15.09.2015

 

 

LOCATIONS

 

Registered Office / Marketing and Admin Office :

B 203, Gopal Palace, Near Nehru Nagar Circle, Satellite Road, Ambavadi, Ahmedabad – 380015, Gujarat, India

Tel. No.:

91-79-27540468

Mobile No.:

91-9920420940 (Mr. Sajan)

Fax No.:

Not Available 

E-Mail :

manojrvora@gmail.com

allvitapharma@gmail.com

Website :

http://www.alvitapharma.co.in

 

 

Plant 1 :

136/B, 2/Motinagar, Susen Tarasali Road, Vadodara – 390010, Gujarat, India

 

 

Plant 2 :

At Plot 901/4-5, GIDC, Ankleshwar, Gujarat, India

 

 

DIRECTORS

 

As on 27.09.2014

 

Name :

Mr. Sajan Parmeswaran Unnithan

Designation :

Director

Address :

Everest Heights, S.No.260 (222), H. No. A/1, Flat-C/410, Gokhiware, Mumbai - 401208, Maharashtra, India

Date of Birth/Age :

31.05.1968

Date of Appointment :

18.07.2011

DIN No.:

03211167

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230GJ2010PTC059305

ALVITA PHARMA PRIVATE LIMITED

Director

18/07/2011

16/09/2010

-

Active

NO

2

U24230GJ2011PTC063594

AZTEC Pharma Private Limited

Director

11/01/2011

11/01/2011

22/12/2014

Active

NO

 

 

Name :

Mr. Manoj Ramaniklal Vora

Designation :

Director

Address :

603, Prathmesh Towers, Gorai Road, Opposite Don-Bosco School, Borivali (West), Mumbai - 400091, Maharashtra, India

Date of Birth/Age :

21.09.1968

Date of Appointment :

18.07.2011

DIN No.:

02352497

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231GJ1989PLC011921

SAVA HEALTHCARE LIMITED

Additional director

25/10/2008

25/10/2008

01/06/2010

Amalgamated

NO

2

U24230GJ2010PTC059305

ALVITA PHARMA PRIVATE LIMITED

Director

18/07/2011

14/07/2010

-

Active

NO

3

U24230GJ2011PTC063594

AZTEC Pharma Private Limited

Director

11/01/2011

11/01/2011

22/12/2014

Active

NO

4

U74120GJ2014PTC078747

NOVAGEN HEALTHCARE PRIVATE LIMITED

Director

14/02/2014

14/02/2014

-

Active

NO

 

 

Name :

Mr. Surendra Kumar Lohia

Designation :

Additional Director

Address :

E-20 B/203, Yogi Nagar, Borivali (East), Mumbai - 400091, Maharashtra, India

Date of Appointment :

02.02.2015

DIN No.:

00171289

 

 

KEY EXECUTIVES

 

Name :

Ms. Pooja

Designation :

Accounts Departmen

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 27.09.2014

 

Names of Shareholders

No. of Shares

%age holding

Manoj Ramaniklal Vora

95000

95.00

Sajan Parmeswaran Unnithan

5000

5.00

Total

100000

100.00

 

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 27.09.2014

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing, Trading and Exporting of Pharmaceuticals Products.

 

 

Products :

Pharmaceuticals Products

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

 

Products :

Pharmaceutical Products

Countries :

  • Asian Countries
  • Eastern European Countries
  • African Countries

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Cheque

 

 

Purchasing :

Cheque

 

 

PRODUCTION STATUS NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

40 (Approximately) 

 

 

Bankers :

Bank Name

Kotak Mahindra Bank Limited

Branch

27 BKC, C 27, G Block, Bandra Kurla Complex, Bandra (East), Mumbai, Maharashtra - 400051, India

Person Name (With Designation)

Not Divulged

Contact Number

91-22-43360000

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Not Divulged

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

Bank Name

Bank of Baroda

Branch

Kandivali (West), Mumbai, Maharashtra, India

 

 

 

Auditors :

 

Name :

Jinesh R Bhagdev and Company

Chartered Accountants

Address :

3, Shyam Sadan  Opposite Sai Raj Garden, 3 Irani Wadi, Kandivali West, Mumbai – 400067, Maharashtra, India

PAN N Income-tax PAN of auditor or auditor's firm :

AKWPB3777D

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Sister Concern :

Aztec Pharma

 

 

CAPITAL STRUCTURE

 

As on 27.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1000000

Equity Shares

Rs.10/- each

Rs.10.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

100000

Equity Shares

Rs.10/- each

Rs.1.000 Million

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

1.000

1.000

0.100

(b) Reserves & Surplus

35.240

15.197

6.914

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

36.240

16.197

7.014

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

0.000

(b) Deferred tax liabilities (Net)

0.203

0.158

0.067

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.203

0.158

0.067

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

0.000

0.000

0.000

(b) Trade payables

68.741

42.495

17.099

(c) Other current liabilities

33.754

21.851

14.773

(d) Short-term provisions

9.621

0.000

2.058

Total Current Liabilities (4)

112.116

64.346

33.930

 

 

 

 

TOTAL

148.559

80.701

41.011

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

8.536

7.779

3.439

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

2.138

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

34.582

26.808

4.321

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

45.256

34.587

7.760

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

27.822

18.916

2.917

(c) Trade receivables

30.977

8.467

7.610

(d) Cash and cash equivalents

29.807

11.690

19.749

(e) Short-term loans and advances

14.697

7.037

2.967

(f) Other current assets

0.000

0.004

0.008

Total Current Assets

103.303

46.114

33.251

 

 

 

 

TOTAL

148.559

80.701

41.011

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

247.450

124.736

77.520

 

 

Other Income

6.333

7.216

NA

 

 

TOTAL                                         (A)

253.783

131.952

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

16.443

9.142

 

 

 

Purchase of Stock-in-trade

154.995

96.815

 

 

 

Changes in Inventories of finished goods, work-in-progress and stock-in-trade

(8.906)

(15.998)

 

 

 

Employee Benefits Expenses

12.709

7.161

 

 

 

Other Expenses

45.335

20.245

 

 

 

TOTAL                                         (B)

220.576

117.365

70.772

(Including Depreciation and Finance)

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

33.207

14.587

 

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

2.333

1.300

 

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

30.874

13.287

 

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

1.164

0.685

 

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                  (G)     

29.710

12.602

6.748

 

 

 

 

 

Less

TAX                                                                  (H)

9.667

4.118

2.105

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

20.043

8.484

4.643

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

15.398

6.914

2.271

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

35.441

15.398

6.914

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

243.680

123.159

75.567

 

TOTAL EARNINGS

243.680

123.159

75.567

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

200.43

84.84

NA

 

 

Particulars

 

 

 

31.03.2015

Sales Turnover

 

 

300.000

 

 

 

 

 

The above information has been parted by Ms. Pooja (Accounts Department)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

NA

NA

NA

Cash generated from operations

NA

NA

NA

Net cash flow from operating activity

NA

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

8.10

6.80

5.99

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

13.42

11.69

NA

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

20.29

15.62

16.45

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.82

0.78

0.96

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.92

0.72

0.98

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

0.100

1.000

1.000

Reserves & Surplus

6.914

15.197

35.240

Net worth

7.014

16.197

36.240

 

 

 

 

long-term borrowings

0.000

0.000

0.000

Short term borrowings

0.000

0.000

0.000

Total borrowings

0.000

0.000

0.000

Debt/Equity ratio

0.000

0.000

0.000

 

 

 

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

77.520

124.736

247.450

 

 

60.908

98.379

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

77.520

124.736

247.450

Profit

4.643

8.484

20.043

 

5.99%

6.80%

8.10%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

FINANCIAL PERFORMANCE

 

The company has earned a net profit before tax of Rs.29.710 Million for the year ended 31st March 2014.

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10544639

23/01/2015

14,400,000.00

KOTAK MAHINDRA BANK LIMITED

27BKC, C 27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai, Maharashtra - 400051, INDIA

C41248386

2

10405597

03/01/2013

7,500,000.00

ING VYSYA BANK LIMITED

ARKADE BHOOMI HEIGHTS, SHOP NO 2 & 3, SHOP NO.1, 
PARTLY, M.G. ROAD, DHANUKARWADI, KHANDIVALI (WEST), Mumbai, Maharashtra - 400067, INDIA

B68823533

 

 

FIXED ASSETS

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

           

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.43

UK Pound

1

Rs.102.40

Euro

1

Rs.75.04

 

 

INFORMATION DETAILS

 

Information Gathered by :

KMN

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

SUJ


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

6

--LIQUIDITY

1~10

6

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

54

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.